A fully human antibody neutralising biologically active human TGFβ2 for use in therapy
- 30 July 1999
- journal article
- Published by Elsevier in Journal of Immunological Methods
- Vol. 227 (1-2) , 17-29
- https://doi.org/10.1016/s0022-1759(99)00060-5
Abstract
No abstract availableKeywords
This publication has 62 references indexed in Scilit:
- Direct demonstration of MuSK involvement in acetylcholine receptor clustering through identification of agonist ScFvNature Biotechnology, 1997
- TGF-β3 Stimulates and Regulates Collagen Synthesis Through TGF-β1-Dependent and Independent MechanismsJournal of Investigative Dermatology, 1997
- Binding Affinity of Transforming Growth Factor-β for Its Type II Receptor Is Determined by the C-terminal Region of the MoleculePublished by Elsevier ,1996
- Human Antibodies with Sub-nanomolar Affinities Isolated from a Large Non-immunized Phage Display LibraryNature Biotechnology, 1996
- Affinity Maturation of a High-affinity Human Monoclonal Antibody Against the Third Hypervariable Loop of Human Immunodeficiency Virus: Use of Phage Display to Improve Affinity and Broaden Strain ReactivityJournal of Molecular Biology, 1996
- Structural motifs involved in human IgG antibody effector functionsEuropean Journal of Immunology, 1993
- The repertoire of human germline vH sequences reveals about fifty groups of VH segments with different hypervariable loopsJournal of Molecular Biology, 1992
- Selection of phage antibodies by binding affinityJournal of Molecular Biology, 1992
- By-passing immunizationJournal of Molecular Biology, 1991
- The Transforming Growth Factor-beta FamilyAnnual Review of Cell Biology, 1990